PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
19-Jun-2020 Crown Bioscience Hosts Innovative Virtual AACR 2020 Conference and Tradeshow Crown Bioscience Inc
19-Jun-2020 PureTech Founded Entity Gelesis Announces Partnership for Commercial Launch of Plenity® in China PureTech Health plc
19-Jun-2020 Livinguard next-generation self-disinfecting technology proven effective in destroying the new coronavirus Livinguard AG
19-Jun-2020 Max Planck researchers feed Proteome AI with PharmaFluidics technology PharmaFluidics
19-Jun-2020 National expansion of Synairgen’s home-based COVID-19 trial of inhaled SNG001 Synairgen plc
19-Jun-2020 Plakous Therapeutics Receives Rare Pediatric Disease and Orphan Drug Designations for Protego-PD(TM) for the Prevention of Necrotizing Enterocolitis Plakous Therapeutics, Inc.
19-Jun-2020 Chi-Med Announces Fruquintinib Granted U.S. FDA Fast Track Designation for Metastatic Colorectal Cancer Chi-Med
19-Jun-2020 Cancer’s reliance on fat could be targeted with new ‘drugs and diet’ treatment The Institute of Cancer Research
19-Jun-2020 4D hosts virtual R&D event providing updates on clinical programmes in oncology and COVID-19 4D pharma plc
19-Jun-2020 Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day WuXi Biologics
19-Jun-2020 Contrast Media Injectors Market Indicates Impressive Growth Rate In Healthcare And Pharmaceuticals Industry Markets and Markets Research Pvt. Ltd.
19-Jun-2020 Aker ASA: Aker BioMarine AS - Contemplated Private Placement and Listing on Merkur Market Aker ASA
19-Jun-2020 Technological Advancements in Glycomics Instrumentation markets and markets
19-Jun-2020 Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata Reistone Biopharma
18-Jun-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
18-Jun-2020 Cell and gene therapy-focused OpenCell Technologies hires MilliporeSigma executive Kevin Gutshall as new CEO BioSTL
17-Jun-2020 Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice Novo Nordisk
17-Jun-2020 Faron receives €2.1 million funding from Business Finland for Traumakine manufacturing Faron Pharmaceuticals Ltd
17-Jun-2020 Kyowa Kirin makes POTELIGEO® (mogamulizumab) available in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome, Two Rare Forms of Non-Hodgkin’s Lymphoma with High Unmet Medical Need Kyowa Kirin
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare